UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis

ESC Heart Failure, 2020-12, Vol.7 (6), p.3298-3309

2020

Volltextzugriff (PDF)

‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor

ESC Heart Failure, 2021-12, Vol.8 (6), p.4444-4453

2021

Volltextzugriff (PDF)

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

European heart journal, 2014-10, Vol.35 (40), p.2797-2815

2014

Volltextzugriff (PDF)

Individual patient data meta‐analysis of the effects of the CARILLON® mitral contour system

ESC Heart Failure, 2020-12, Vol.7 (6), p.3383-3391

2020

Volltextzugriff (PDF)

Targeting breathlessness in heart failure

ESC Heart Failure, 2019-12, Vol.6 (6), p.1103-1104

Coats, Andrew J. Stewart

2019

Volltextzugriff (PDF)

Validating the HFA‐PEFF score – or how to define a disease?

European journal of heart failure, 2020-03, Vol.22 (3), p.428-431

Stewart Coats, Andrew J.

2020

Volltextzugriff (PDF)

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure

ESC Heart Failure, 2022-04, Vol.9 (2), p.885-893

2022

Volltextzugriff (PDF)

Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE‐FMR trial

ESC Heart Failure, 2021-04, Vol.8 (2), p.872-878

2021

Volltextzugriff (PDF)

Technology‐assisted clinical care

European journal of heart failure, 2019-09, Vol.21 (9), p.1088-1089

Stewart Coats, Andrew J.

2019

Volltextzugriff (PDF)

Heart failure 2016: still more questions than answers

International journal of cardiology, 2017-01, Vol.227, p.766-777

2017

Volltextzugriff (PDF)

The muscle hypothesis revisited

European journal of heart failure, 2017-12, Vol.19 (12), p.1710-1711

Stewart Coats, Andrew J.

2017

Volltextzugriff (PDF)

Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)

Journal of cachexia, sarcopenia and muscle, 2016-06, Vol.7 (3), p.355-365

2016

Volltextzugriff (PDF)

Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions

European heart journal supplements, 2019-12, Vol.21 (Suppl L), p.L36-L38

Coats, Andrew J Stewart

2019

Volltextzugriff (PDF)

The enigma of beta-blockers, atrial fibrillation and heart failure

International journal of cardiology, 2018-12, Vol.273, p.191-192

Stewart Coats, Andrew J.

2018

Volltextzugriff (PDF)

Sacubitril/valsartan: Can haemodynamic monitoring help with up-take?

International journal of cardiology, 2018-11, Vol.271, p.202-203

Stewart Coats, Andrew J.

2018

Volltextzugriff (PDF)

Intravenous ferric carboxymaltose for heart failure with iron deficiency

European journal of heart failure, 2018-01, Vol.20 (1), p.134-135

Stewart Coats, Andrew J.

2018

Volltextzugriff (PDF)

Heart rate as a target: Ready for pole position?

International journal of cardiology, 2018-06, Vol.260, p.131-132

Stewart Coats, Andrew J.

2018

Volltextzugriff (PDF)

The need for both animal models and clinical trials in cachexia, but is a man more like a mouse than another man?

International journal of cardiology, 2018-04, Vol.256, p.36-36

Stewart Coats, Andrew J.

2018

Volltextzugriff (PDF)

Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: An individual patient's data meta-analysis of randomized controlled trials

International journal of cardiology, 2014-08, Vol.175 (2), p.352-357

2014

Volltextzugriff (PDF)

Physical function and exercise training in older patients with heart failure

Nature reviews cardiology, 2017-09, Vol.14 (9), p.550-559

2017

Volltextzugriff (PDF)

Common Co-Morbidities in Heart Failure – Diabetes, Functional Mitral Regurgitation and Sleep Apnoea

International Journal of Heart Failure, 2019, 1(1), , pp.25-

Stewart Coats, Andrew J.

2019

Volltextzugriff (PDF)

Beta-blockers, hypertension, and weight gain: the farmer, the chicken, and the egg

Hong Kong Medical Journal, 2020-02, Vol.26 (1), p.6-7

Coats, A J S

2020

Volltextzugriff (PDF)

Early abnormalities of cerebral blood flow in mild non‐ischaemic heart failure: part of a whole‐body response?

European journal of heart failure, 2017-02, Vol.19 (2), p.269-270

Stewart Coats, Andrew J.

2017

Volltextzugriff (PDF)

A comparison of research into cachexia, wasting and related skeletal muscle syndromes in three chronic disease areas

International journal of cardiology, 2017-05, Vol.235, p.33-36

2017

Volltextzugriff (PDF)

Eplerenone's role in the management of complex cardiovascular disorders

International journal of cardiology, 2015-12, Vol.200, p.1-2

2015

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(83)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis

‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

Individual patient data meta‐analysis of the effects of the CARILLON® mitral contour system

Targeting breathlessness in heart failure

Validating the HFA‐PEFF score – or how to define a disease?

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure

Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE‐FMR trial

Technology‐assisted clinical care

Heart failure 2016: still more questions than answers

The muscle hypothesis revisited

Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)

Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions

The enigma of beta-blockers, atrial fibrillation and heart failure

Sacubitril/valsartan: Can haemodynamic monitoring help with up-take?

Intravenous ferric carboxymaltose for heart failure with iron deficiency

Heart rate as a target: Ready for pole position?

The need for both animal models and clinical trials in cachexia, but is a man more like a mouse than another man?

Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: An individual patient's data meta-analysis of randomized controlled trials

Physical function and exercise training in older patients with heart failure

Common Co-Morbidities in Heart Failure – Diabetes, Functional Mitral Regurgitation and Sleep Apnoea

Beta-blockers, hypertension, and weight gain: the farmer, the chicken, and the egg

Early abnormalities of cerebral blood flow in mild non‐ischaemic heart failure: part of a whole‐body response?

A comparison of research into cachexia, wasting and related skeletal muscle syndromes in three chronic disease areas

Eplerenone's role in the management of complex cardiovascular disorders

Suchergebnisse filtern